Utilities Healthcare Sector

Monopar Therapeutics

Market Cap: US$196.4m

A clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States.

Instil Bio

Market Cap: US$196.1m

A clinical-stage biopharmaceutical company, focuses on developing a pipeline of novel therapies.

Inhibrx Biosciences

Market Cap: US$195.9m

A clinical-stage biopharmaceutical company, engages in the development of biologic therapeutics for people with life-threatening conditions.

Codexis

Market Cap: US$193.9m

Provides enzymatic solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, and enhance novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China.

4basebio

Market Cap: UK£142.1m

Engages in the research, development, manufacturing, and commercialization of synthetic DNA and RNA products, and non-viral vector solutions in Europe, the United States, and internationally.

Monash IVF Group

Market Cap: AU$294.2m

Provides assisted reproductive and specialist women imaging services in Australia and Malaysia.

Actuate Therapeutics

Market Cap: US$191.3m

A clinical-stage biopharmaceutical company, develops therapies for the treatment of cancers in the United States.

Avacta Group

Market Cap: UK£140.4m

Develops cancer drugs and in vitro diagnostics in the United Kingdom, France, North America, South Korea, rest of Europe, and internationally.

Eledon Pharmaceuticals

Market Cap: US$189.8m

Operates as a clinical stage biotechnology company.

Pacific Smiles Group

Market Cap: AU$291.7m

Owns and operates dental centers under the Pacific Smiles Dental Centres and Nib Dental Care Centres names in Australia.

Alumis

Market Cap: US$187.7m

A clinical stage biopharmaceutical company, focuses on the development and commercialization of medicines for autoimmune disorders.

ProQR Therapeutics

Market Cap: US$187.5m

A biotechnology company, focuses on the discovery and development of novel therapeutic medicines.

High Tide

Market Cap: CA$254.1m

Engages in the cannabis retail business in Canada, the United States, and internationally.

Omeros

Market Cap: US$184.0m

A clinical-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting immunologic diseases.

Panamera Holdings

Market Cap: US$182.5m

Does not have significant operations.

Utah Medical Products

Market Cap: US$181.9m

Provides medical devices for the healthcare industry worldwide.

Voyager Therapeutics

Market Cap: US$181.5m

A biotechnology company, focuses on the human genetics for the cure of neurological diseases.

Deltex Medical Group

Market Cap: US$180.6m

Manufactures, markets, and sells oesophageal doppler haemodynamic monitoring systems under the TrueVue name in the United Kingdom, the United States, and internationally.

4D Molecular Therapeutics

Market Cap: US$179.3m

A late-stage biotechnology company, engages in the development of adeno-associated virus vectors from its proprietary synthetic vector discovery platform, Therapeutic Vector Evolution in the Netherlands and the United States.

AFT Pharmaceuticals

Market Cap: NZ$295.7m

Engages in the development, marketing, and distribution of pharmaceutical products in New Zealand, Australia, Asia, and internationally.

Organigram Global

Market Cap: CA$242.3m

Engages in the production and sale of cannabis and cannabis-derived products in Canada.

DiaMedica Therapeutics

Market Cap: US$176.7m

A clinical stage biopharmaceutical company, focuses on improving the lives of people suffering from severe ischemic diseases.

CVRx

Market Cap: US$176.3m

A commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally.

ALT5 Sigma

Market Cap: US$175.9m

Provides blockchain-powered technologies worldwide.

Cybin

Market Cap: US$175.0m

A clinical-stage biopharmaceutical company, focuses on developing psychedelic-based therapeutics for patients with mental health conditions.

biote

Market Cap: US$174.0m

Operates in practice-building business within the hormone optimization space.

Spectral Medical

Market Cap: CA$236.6m

Focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally.

Inogen

Market Cap: US$171.8m

A medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally.

Electromed

Market Cap: US$171.7m

Develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally.

Compugen

Market Cap: US$171.1m

A clinical-stage therapeutic discovery and development company, engages in the research, development, and commercialization of therapeutics and product candidates in Israel, the United States, and Europe.

Prime Medicine

Market Cap: US$170.0m

A biotechnology company, engages in delivering genetic therapies to address the spectrum of diseases by deploying gene editing technology in the United States.

INmune Bio

Market Cap: US$168.7m

A clinical-stage immunology company, focuses on developing drugs to reprogram the patients innate immune system to treat disease in the United States.

Journey Medical

Market Cap: US$167.7m

Focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.

OmniAb

Market Cap: US$167.6m

A biotechnology company, licenses discovery research technology to pharmaceutical and biotech companies, and academic institutions to enable the discovery of therapeutics in the United States, Europe, Japan, China, and Canada.

Profound Medical

Market Cap: CA$228.7m

Operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland.

Anika Therapeutics

Market Cap: US$166.2m

A joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, sports medicine, and arthrosurface joint solutions in the United States, Europe, and internationally.